AIIMS Delhi has recently launched an advanced robotic surgery program using the da Vinci robotic system to perform complex cancer surgeries with greater precision. Announced on September 27, 2025, this initiative aims to revolutionize cancer treatment by offering minimally invasive surgical options that improve outcomes and reduce recovery times for patients.

The da Vinci robotic system allows surgeons to operate with enhanced accuracy, flexibility, and control through small incisions, minimizing trauma to healthy tissues. This state-of-the-art technology is especially beneficial for delicate cancer surgeries that require meticulous precision, such as those involving the prostate, lungs, and gastrointestinal tract.

AIIMS Delhi’s program is also notable for its commitment to providing free treatment to eligible cancer patients. This effort ensures that advanced surgical care is accessible to a broader population, regardless of their financial status. By integrating robotic-assisted surgeries into public healthcare, AIIMS is setting a benchmark for affordable, high-quality cancer care in India.

The robotic surgery program is expected to reduce postoperative complications and shorten hospital stays, improving the overall patient experience. It also allows for quicker resumption of daily activities, which is critical for cancer patients’ physical and emotional well-being.

The launch reflects AIIMS Delhi’s continuous dedication to adopting cutting-edge medical technologies and advancing cancer treatment methodologies. It aligns with global trends in healthcare, where robotic surgeries are becoming standard practice for complex procedures.

Overall, the introduction of the da Vinci system at AIIMS Delhi represents a significant step forward in cancer care, combining technological innovation with compassionate patient support. This program promises to enhance surgical precision, expand treatment options, and deliver better outcomes for cancer patients across the country.